Endogenous Metabolite (EM) Information
Endogenous Metabolite (EM) Information | ||||||
---|---|---|---|---|---|---|
EM ID |
EM00093
|
|||||
EM Name |
Xanthosine
|
|||||
Synonyms |
xanthosine; Xanthine riboside; 9-beta-D-Ribofuranosylxanthine; UNII-BM66HT53C3; 2,3-Dihydroxanthosine; beta-D-Ribofuranoside, xanthine-9; AI3-52693; BM66HT53C3; CHEBI:18107; 1H-Purine-2,6-dione, 3,9-dihydro-9-beta-D-ribofuranosyl-; 9-((2R,3R,4S,5R)-3,4-Dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-9H-purine-2,6-diol; XanthosineDihydrate; 9-[(4S,2R,3R,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,3-dihydropurine -2,6-dione; xanthosin; EINECS 205-679-9; NSC 18930; Xanthosine, 9-beta-D-
|
|||||
Structure |
<iframe style="width: 300px; height: 300px;" frameborder="0" src="https://embed.molview.org/v1/?mode=balls&cid=64959"></iframe>
|
|||||
3D MOL | 2D MOL | |||||
Formula |
C10H12N4O6
|
|||||
Canonical SMILES |
C1=NC2=C(N1C3C(C(C(O3)CO)O)O)NC(=O)NC2=O
|
|||||
InChI |
InChI=1S/C10H12N4O6/c15-1-3-5(16)6(17)9(20-3)14-2-11-4-7(14)12-10(19)13-8(4)18/h2-3,5-6,9,15-17H,1H2,(H2,12,13,18,19)/t3-,5-,6-,9-/m1/s1
|
|||||
InChIKey |
UBORTCNDUKBEOP-UUOKFMHZSA-N
|
|||||
CAS Number |
CAS 146-80-5
|
|||||
Pharmaceutical Properties | Molecular Weight | 284.23 | Topological Polar Surface Area | 146 | ||
Heavy Atom Count | 20 | Rotatable Bond Count | 2 | |||
Hydrogen Bond Donor Count | 5 | Hydrogen Bond Acceptor Count | 7 | |||
XLogP |
-2.4
|
|||||
PubChem CID | ||||||
ChEBI ID |
CHEBI:18107
|
|||||
DT(s) "handling" This EM | MRP6 | Transporter Info | Multidrug resistance-associated protein 6 | [1] | ||
OCT-2 | Transporter Info | Organic cation transporter 2 | [2] | |||
References | ||||||
1 | Untargeted Metabolomics Analysis of ABCC6-Deficient Mice Discloses an Altered Metabolic Liver Profile. J Proteome Res. 2016 Dec 2;15(12):4591-4600. | |||||
2 | Pharmacogenetics meets metabolomics: discovery of tryptophan as a new endogenous OCT2 substrate related to metformin disposition. PLoS One. 2012;7(5):e36637. |
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.